FDA Approves AI Device to Help Doctors Spot Common Skin Cancers
-
The FDA approved DermaSensor, an AI-powered device to help providers detect common skin cancers. It is not for general screening or home use.
-
DermaSensor uses light to analyze lesions already identified as suspicious. Its algorithm tells the provider if referral to a specialist is recommended.
-
It is designed for use by primary care providers to determine if a suspicious lesion merits referral to a dermatologist.
-
DermaSensor can help detect 3 common skin cancers but not rare types. Its main benefit is reducing unnecessary specialist visits.
-
Patients cannot access DermaSensor themselves. To get screened for skin cancer, patients should still see a dermatologist annually.